IL1B and cancer: We hypothesized that the SIRPγhi CSLCs may regulate CD47 expression in CSLCs and bulk cancer cell population through autocrine or paracrine signaling, particularly as previous studies revealed that cytokines such as TNF-α and IL-1β can stimulate CD47 expression (37).